Canada reports 1st blood clot in AstraZeneca COVID-19 vaccine recipient
Canada announced on Tuesday its first report of a rare blood clot in a person who had received the AstraZeneca COVID-19 vaccine.
The Public Health Agency of Canada (PHAC) and the Quebec health ministry said the female patient, whose age was not revealed, is recovering at home.
In late March, Canadian health regulators said AstraZeneca’s COVID-19 vaccine cannot be administered to people under the age of 55 due to concerns over reports of rare blood clots.
Canada announced on Tuesday its first report of a rare blood clot in a person who had received the AstraZeneca COVID-19 vaccine.
The Public Health Agency of Canada (PHAC) and the Quebec health ministry said the female patient, whose age was not revealed, is recovering at home.
In late March, Canadian health regulators said AstraZeneca’s COVID-19 vaccine cannot be administered to people under the age of 55 due to concerns over reports of rare blood clots.